Ian Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52 episode artwork

EPISODE · Dec 12, 2025 · 39 MIN

Ian Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52

from Talking Precision Medicine · host Genialis

In this episode, I’m joined by my longtime friend Ian Simon, Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the State Department, and the Office of Long Covid. We talk about de-risking young biotech companies, what Covid taught us about science and public health, and how new technologies like AI might change how we do science altogether. ⁠⁠⁠TPM E52 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Episode 52 links:Ian Simon on LinkedInAspis Intelligence

Episode metadata supplied by the publisher feed · Published Dec 12, 2025

Embed this episode

Ready to play

Ian Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52

0:00 39:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Precision Medicine?

This episode is 39 minutes long.

When was this Talking Precision Medicine episode published?

This episode was published on December 12, 2025.

Can I download this Talking Precision Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!